tetrahydrocortisol has been researched along with betadex in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, ZD; Sotomayor, EA; Teicher, BA | 1 |
Ara, G; Chen, YN; Holden, S; Huang, ZD; Khandekar, V; Sotomayor, EA; Teicher, BA | 1 |
2 other study(ies) available for tetrahydrocortisol and betadex
Article | Year |
---|---|
Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; beta-Cyclodextrins; Bleomycin; Cisplatin; Cyclodextrins; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Lung Neoplasms; Mice; Mice, Inbred C57BL; Minocycline; Neoplasm Transplantation; Tetrahydrocortisol; Tumor Cells, Cultured | 1992 |
beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; beta-Cyclodextrins; Cell Division; Cell Hypoxia; Cyclodextrins; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Minocycline; Tetrahydrocortisol; Tumor Cells, Cultured | 1993 |